compass icon

Our Mission

To improve the health of the world’s population by leveraging the GeoSentinel network and other dedicated health professionals to enable the early detection of and response to infectious diseases and other health threats.

binoculars icon

Our Vision

A safer world, where the threat and impact of infections and other health risks is minimized.

Dr. Eli Schwartz, our Tel Aviv site Director (seen above) at a Ukrainian refugee center in Poland.

The GeoSentinel Foundation Inc. supports GeoSentinel, a collaborative network early warning system originally created by the International Society of Travel Medicine (ISTM) and the U.S. Centers for Disease Control and Prevention (CDC). Through surveillance and research, GeoSentinel detects disease trends and outbreaks in mobile populations, including tourists, business travelers, migrants, refugees and victims of human trafficking.

GeoSentinel operates on six continents with dedicated and passionate clinicians, researchers and educators who seek to answer key questions related to infectious and other diseases.

The Foundation also supports other projects which enhance global health at the local, regional and international levels.

A TIMELY START

Enabled by generous donations, much of our first two-years’ work, starting in March 2020, focused on the COVID-19 pandemic:

new therapeutics icon
Testing new therapeutics for frontline clinicians
finger stick icon
Developing a finger-stick test for severity of infection
mother with newborn icon
Improving diagnostic strategies
molecule icon
Using modern molecular diagnostic methods to study SARS-CoV-2 transmission in select groups

We also conducted research on arboviral (mosquito-transmitted) infections with a focus on emerging diseases like chikungunya and re-emerging diseases like dengue.

Empowering Research

The Foundation enables high-impact research and discoveries through its 71 GeoSentinel Network clinics in 29 countries. Within this network, some of the world’s most talented scientists are already at work developing novel diagnostic tests and treatments for emerging and re-emerging infectious diseases.